|
|
|
|
| LEADER |
01792nam a2200325 u 4500 |
| 001 |
EB001897100 |
| 003 |
EBX01000000000000001060105 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200523 r ||| eng |
| 100 |
1 |
|
|a Banerjee, Srabani
|
| 245 |
0 |
0 |
|a Acetylcysteine for patients requiring mucous secretion clearance
|h Elektronische Ressource
|b a review of clinical effectiveness and safety
|c authors, Srabani Banerjee, Suzanne McCormack
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c June 14, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (22 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Adult
|
| 653 |
|
|
|a Respiratory Tract Diseases / drug therapy
|
| 653 |
|
|
|a Acetylcysteine / therapeutic use
|
| 653 |
|
|
|a Acetylcysteine / administration & dosage
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Mucus
|
| 700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546019
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to review the comparative clinical effectiveness and safety of NAC for treating adult patients requiring mucous secretion clearance. Additionally, for this patient population, the clinical effectiveness of treatment with nebulized acetylcysteine versus oral acetylcysteine will be reviewed. A subsequent report will review the evidence-based guidelines regarding NAC for the treatment of adult patients requiring mucous secretion clearance
|